PSNL.NASDAQPersonalis, INC

Form 4: Personalis Inc. Director Bloom Receives Stock Option Grant

Sentiment:

SEC Form 4 Filing


Director Olivia Kyusuk Bloom received a stock option grant for 50,000 shares of Personalis, Inc. common stock on May 17, 2024.

Summary

  • Olivia Kyusuk Bloom, a director of Personalis, Inc., was granted a stock option to purchase 50,000 shares of common stock on May 17, 2024.
  • The exercise price of the stock option is $1.40 per share.
  • The options vest on the earlier of the one-year anniversary of the grant date or the day prior to the company's next annual meeting of stockholders occurring after the grant date, contingent upon continuous service.
  • The options will vest immediately upon a Change in Control of the company.
  • The options expire on May 17, 2034.

Sentiment

Score: 7

Explanation: The document reflects a standard executive compensation practice, which is generally viewed positively as it aligns management interests with shareholders. The grant itself is a neutral event, but the incentive structure is a positive sign.

Positives

  • The stock option grant aligns the director's interests with those of the shareholders.
  • The vesting schedule incentivizes continued service and commitment to the company.
  • The Change in Control provision provides additional incentive for the director to support strategic transactions that benefit shareholders.

Industry Context

Stock option grants are a common form of executive compensation in the biotechnology industry, aligning management's interests with shareholder value creation.

Comparison to Industry Standards

  • Stock option grants are a standard component of compensation packages for directors and executives in publicly traded companies, particularly in the biotech sector.
  • Companies like Illumina, Inc. and Exact Sciences Corp. also utilize stock options as part of their executive compensation plans to incentivize performance and align interests with shareholders.
  • The vesting schedule and exercise price are typical for such grants, designed to reward long-term value creation.

Stakeholder Impact

  • Shareholders: The stock option grant aligns the director's interests with increasing shareholder value.
  • Employees: The grant may have a positive impact on employee morale as it signals confidence in the company's future.

Key Dates

DateDescription
05/17/2024Date of stock option grant and transaction.
05/17/2034Expiration date of the stock option.
05/21/2024Date of signature by Attorney-in-Fact.

Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.